Page 5 - Latest Updates on Diabetes
New diabetes drug achieves blood sugar, weight targets faster: Research
T2D is a chronic and progressive condition in which the body does not make or use insulin normally, leading to high levels of glucose in the blood
 "New diabetes drug achieves blood sugar, weight targets faster: Research")
Control of blood sugar in mothers with diabetes better for infants: Study
Research led by Caroline Crowther of the University of Auckland, New Zealand, and a team, the findings were published in the journal PLOS Medicine
 "Control of blood sugar in mothers with diabetes better for infants: Study")
Pricing regulator closely watching prices of diabetes drug going off patent
Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations
 "Pricing regulator closely watching prices of diabetes drug going off patent")
Zydus Life launches generic version of Sitagliptin for type 2 diabetes
Zydus Lifesciences Ltd on Friday said it has launched the generic version of sitagliptin in India under the brand names Sitaglyn and Siglyn to address type 2 diabetes.
 "Zydus Life launches generic version of Sitagliptin for type 2 diabetes")
Going off-patent, key diabetes drug likely to get 50-70% cheaper
Several drugs going off-patent in the anti-diabetes category have shaken up the market share dynamics
US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients
On Tuesday, the CDC, citing case reports and concerns that relapsed patients could spread the virus, issued its advisory that Paxlovid users should isolate for a second five days if symptoms rebound
 "US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients")
Tech firm MFine helps people monitor blood pressure, glucose on smartphones
MFine has democratised health care at home by bringing these solutions on to devices that are more ubiquitous and affordable than wearables
 "Tech firm MFine helps people monitor blood pressure, glucose on smartphones")
Long Covid-induced diabetes, depression can be treated by exercise: Study
Though no medically recognized treatment exists for Long Covid, a study suggests that exercise might break cycle of inflammation that develops diabetes and depression months after a person recovers
 "Long Covid-induced diabetes, depression can be treated by exercise: Study")
Zydus gets regulator nod to market generic diabetes drug in American
Zydus Group on Wednesday said it has received final approval from the US health regulator to market diabetes medication Dapagliflozin tablets in the American market.
 "Zydus gets regulator nod to market generic diabetes drug in American")
Pharma company Abbott ties up with health tech firms for diabetes care
Abbott on Tuesday said it has tied up with health-tech firms like BeatO, Sugar.fit, PharmEasy, GOQii, 1MG and Zyla for diabetes care
 "Pharma company Abbott ties up with health tech firms for diabetes care")
India's diabetes care market to reach $60 bn in next 10 yrs: Report
The diabetes care market in India is expected to reach about $60 billion in the next 10 years, from approximately $17 billion in FY2021, a new report said
 "India's diabetes care market to reach $60 bn in next 10 yrs: Report")
Statsguru: Obesity to diabetes, 6 charts explain health concerns for India
Data shows that obesity is increasingly growing among both men and women
 "Statsguru: Obesity to diabetes, 6 charts explain health concerns for India")
Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
These injections will help control high blood sugar in adult and pediatric patients with type-1 diabetes and adults with type-2
 "Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US")
IMA urges Covid vax, including booster dose if needed, for all diabetics
Noticing their vulnerabilities, IMA on Sunday demanded Covid-19 vaccination for all diabetes patients, including a third dose, if needed.
 "IMA urges Covid vax, including booster dose if needed, for all diabetics")
Post-Covid fatigue is most prevalent in diabetes patients: Study
People with Type-2 diabetes who also suffered Covid-19 are more likely to experience severe fatigue than those who did not have the infectious disease, according to a new study released on Thursday
 "Post-Covid fatigue is most prevalent in diabetes patients: Study")
Germany's Boehringer, Indian pharma in legal battle over diabetes drug
The German drug maker has obtained interim injunctions against MSN Labs and Dr Reddy's Lab
 "Germany's Boehringer, Indian pharma in legal battle over diabetes drug")
NPPA fixes price caps for 12 anti-diabetic medicines
These include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet
 "NPPA fixes price caps for 12 anti-diabetic medicines")
Study finds why people with diabetes develop severe Covid-19
A recent study by a team of international clinical researchers reveals the mechanism behind cytokine storm during coronavirus infection.
Startup Sugar.fit, which aims to reverse diabetes, to raise $10 million
Health and fitness firm Cure.fit and two others to invest the funds in a deal likely to by September
 "Startup Sugar.fit, which aims to reverse diabetes, to raise $10 million")
Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy
In India, Wockhardt aims to make 2 billion doses of Covid-19 vaccines within the next one or two years but has not disclosed the identity of the tie-ups
 "Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy")
